Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
CAMBRIDGE, Mass., August 14, 2026--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address…





